Peptide record

TPDB64986

Epidermal growth fac Blood-Brain Barrier modified_plain modified
53 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB64986
Epidermal growth fac
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A 53-aa modified blood-brain barrier peptide sequence curated from Peptipedia, with an available 3D structural model.
Chemical: Cys6-Cys20, Cys14-Cys31, Cys33-Cys42
Sequence
NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELR
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
53 reviewed residue count
Cys6-Cys20, Cys14-Cys31, Cys33-Cys42 Activity
Linear Activity
Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys-Leu-His-Asp-Gly-Val-Cys-Met-Tyr-Ile-Glu-Ala-Leu-Asp-Lys-Tyr-Ala-Cys-Asn-Cys-Val-Val-Gly-Tyr-Ile-Gly-Glu-Arg-Cys-Gln-Tyr-Arg-Asp-Leu-Lys-Trp-Trp-Glu-Leu-Arg Activity
[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C Activity
Evidence Records 6 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
34 min

Assay & Model

Efflux study ICU
half life, brain

Source & Reference

NA
B3Pdb

Other

human,synthetic
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.02 min-1

Assay & Model

Efflux study ICU
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

human,synthetic
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.0121 ml/g

Assay & Model

Capillary depletion
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

human,synthetic
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.00684 ml/g

Assay & Model

Capillary depletion
Capillary depletion (capillary/serum)

Source & Reference

NA
B3Pdb

Other

human,synthetic
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
-1.37

Assay & Model

Shake Flask
Log P

Source & Reference

NA
B3Pdb

Other

human,synthetic
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
0.00202 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

human,synthetic
Intravenous
Saturable
Direct iodination
Additional Detail Fields 1 fields
Intravenous